Evidence map›Paper›PMID 42099866›Full record

ReviewFrontiers in bioengineering and biotechnology2026

Metal nanozyme sensors with different modes: biomedical applications and research advances.

Banghui Wang, Tianyi Zhang, Meiling Zhao, Weiwei Song, Maojin Tian

Abstract readReview
In one paragraph

Review in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Banghui Wang *Department of Cardiology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Tianyi Zhang *Department of Critical Care Medicine, Shandong Provincial Hospital affiliated to Shandong First Medical University, Jinan, China.
Meiling ZhaoDepartment of Critical Care Medicine, Zibo Central Hospital, Zibo, China.
Weiwei SongDepartment of Critical Care Medicine, Zibo Central Hospital, Zibo, China.
Maojin TianDepartment of Critical Care Medicine, Zibo Central Hospital, Zibo, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, with the continuous advancement of nanotechnology, nanozymes have demonstrated tremendous potential in biomedical applications. By mimicking the catalytic activities of biological enzymes such as oxidases, peroxidases, and superoxide dismutases, nanozymes can be employed to detect various analytes, enabling their application in sensors. In the research of nanozymes, owing to their unique electronic structures and abundant surface active sites, endow metal nanozymes with both tunable high activity and strong stability. They can not only efficiently mimic the catalytic functions of various natural enzymes such as peroxidases, oxidases, and superoxide dismutases, but some types also exhibit high catalytic efficiency, even surpassing the natural enzymes themselves. This ability to mimic enzymatic activity endows nanozymes with distinctive properties. Signal conversion modes for metal nanozymes encompass multiple forms, including colorimetric, electrochemical, Surface-Enhanced Raman Scattering, and fluorescent detection. Herein, this review categorizes metal nanozyme sensors with different sensing modes into three major types: single-mode, dual-mode, and multi-mode. It summarizes the application potential of various sensor modes in scenarios such as biomarker detection, pathogen screening, and disease diagnosis, while analyzing current challenges including catalytic specificity and mode-to-mode synergy. Furthermore, this review explores the core challenges confronting metal nanozyme sensors and outlines future development directions, providing insights for the research and development of novel sensing technologies and their biomedical applications.

Indexed as

biomedical applicationsdual-mode sensingmetal nanozymesmulti-mode sensingsingle-mode sensing

Identifiers

PMID42099866
PMCPMC13144114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.